Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice
Zhongwen Feng, Lijun Pang, Siyun Chen, Xiaohong Pang, Yushen Huang, Qian Qiao, Yinglian Wang, Sayyaphone Vonglorkham, Quanfang Huang, Xing Lin, Jinbin Wei
Topics & Concepts
Protein kinase BPI3K/AKT/mTOR pathwayFatty liverSilibininTLR4EndocrinologySteatohepatitisInternal medicineApoptosisHepatocyteSignal transductionChemistryBiologyCancer researchInflammationMedicineBiochemistryDiseaseIn vitroLiver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and ProtectionGenomics, phytochemicals, and oxidative stress